APHON 2013

 
 
 

The APHON 37th Annual Conference and Exhibit took place September 19-21, 2013, in Louisville, Kentucky.

 

Fatigue levels decrease after leukemia/lymphoma diagnosis, study suggests

Jen Smith Read Article
Published: 10/01/13

child_sleeping_Graham_Crumb_230.jpg
Sleeping child
Credit: Graham Crumb

Researchers have uncovered new insights into the course of sleep and fatigue in newly diagnosed pediatric and adolescent oncology patients. The team found that sleep habits remained relatively stable within the first few months of diagnosis for patients with all cancer types studied. But levels of fatigue differed. Fatigue remained high throughout the study period for solid tumor patients, but it decreased significantly in leukemia and lymphoma patients. [Read Article]

Abdominal massage in pediatric cancer

Jen Smith Read Article
Published: 09/30/13

massage_techniques_clinical_social_worker_demonstrating_Credit_Jason_Swink_220.jpg
Social worker demonstrates
massage techniques
Credit: Jason Swink

Abdominal massage may help alleviate constipation in pediatric cancer patients receiving vincristine, results of a small pilot study suggest. Researchers found that massage performed by an at-home caregiver significantly reduced patients’ scores on the Pediatric Constipation Assessment Scale. However, the intervention did not significantly increase the number of bowel movements. Nevertheless, the investigators noted that at-home abdominal massage was feasible, and its efficacy . . . [Read Article]

Reducing distress in pediatric cancer patients

Jen Smith Read Article
Published: 09/27/13

APHON_aerial_David_Knapp_220.jpg
Attendees at the APHON 37th
Annual Conference and Exhibit
Credit: David Knapp

Results of a pilot study indicate that biofeedback and relaxation interventions may help diminish pre-procedural distress in pediatric cancer patients. Children with cancer often experience distress in anticipation of needle sticks, lumbar punctures, bone marrow aspirations, and biopsies, according to Debra Parker Shockey, DNP, RN, CPNP, of Virginia Commonwealth University in Richmond. So she and her colleagues wanted to determine if relaxation breathing . . . [Read Article]

Looking beyond CLABSIs to improve care

Jen Smith Read Article
Published: 09/26/13

red_blood_cells_positive_staphyloccus_infection_Credit_Bill_Branson_208.jpg
Red blood cells positive for
Staphylococcus infection
Credit: Bill Branson

Hospitals should focus their efforts on reducing all positive blood culture events (PBCE), not just central lineā€associated bloodstream infections (CLABSIs), according to a pair of speakers at the APHON 37th Annual Conference and Exhibit. The speakers noted that reducing the incidence of CLABSIs has become a focus for many hospitals, and implementing best practice bundles for central line care has proven successful. But this intervention has not . . . [Read Article]

Risk factors for DD in leukemia patients

Jen Smith Read Article
Published: 09/25/13

baby_smiling_Credit_Petr_Kratochvil_230.jpg
Smiling baby
Credit: Petr Kratochvil

Results of a single-center study offer additional insight regarding risk factors for diaper dermatitis (DD) in children with leukemia. Investigators conducted retrospective and prospective analyses of pediatric leukemia patients treated at The Children’s Hospital of Philadelphia (CHOP) in Pennsylvania. The results revealed that DD occurred often in patients receiving cytarabine and in those taking pain medications. However, neither the incidence of diarrhea nor . . . [Read Article]

Banked EBV CTLs prove effective against PTLDs

Jen Smith Read Article
Published: 09/24/13

APHON_2013_attendees_Credit_David_Knapp_220.jpg
Attendees at the APHON 37th
Annual Conference and Exhibit
Credit: David Knapp

Researchers have found more evidence to suggest that cytotoxic T lymphocytes targeting Epstein-Barr virus (EBV CTLs) are superior to standard treatment options for post-transplant lymphoproliferative disorders (PTLDs). In a small study, donor-derived EBV CTLs elicited complete responses in a majority of patients, even those who received banked cells that were partially HLA-matched. Furthermore, side effects associated with the cells were minimal.  [Read Article]

    {title}

    {icon} {author} Read Article
    Published: {pubDate}

    {summary}